PRINIVIL Drug Patent Profile
✉ Email this page to a colleague
When do Prinivil patents expire, and what generic alternatives are available?
Prinivil is a drug marketed by Merck and is included in one NDA.
The generic ingredient in PRINIVIL is lisinopril. There are twenty-one drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the lisinopril profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prinivil
A generic version of PRINIVIL was approved as lisinopril by ASCENT PHARMS INC on July 1st, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRINIVIL?
- What are the global sales for PRINIVIL?
- What is Average Wholesale Price for PRINIVIL?
Summary for PRINIVIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 81 |
| Clinical Trials: | 12 |
| Drug Prices: | Drug price information for PRINIVIL |
| What excipients (inactive ingredients) are in PRINIVIL? | PRINIVIL excipients list |
| DailyMed Link: | PRINIVIL at DailyMed |
Recent Clinical Trials for PRINIVIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| St. Jude Children's Research Hospital | Phase 2 |
| Memorial Health University Medical Center | Phase 1 |
| Centre Hospitalier Universitaire de Saint Etienne | Phase 4 |
US Patents and Regulatory Information for PRINIVIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | PRINIVIL | lisinopril | TABLET;ORAL | 019558-006 | Jan 28, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | PRINIVIL | lisinopril | TABLET;ORAL | 019558-003 | Dec 29, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | PRINIVIL | lisinopril | TABLET;ORAL | 019558-001 | Dec 29, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | PRINIVIL | lisinopril | TABLET;ORAL | 019558-002 | Dec 29, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | PRINIVIL | lisinopril | TABLET;ORAL | 019558-004 | Oct 25, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PRINIVIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merck | PRINIVIL | lisinopril | TABLET;ORAL | 019558-006 | Jan 28, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Merck | PRINIVIL | lisinopril | TABLET;ORAL | 019558-003 | Dec 29, 1987 | ⤷ Sign Up | ⤷ Sign Up |
| Merck | PRINIVIL | lisinopril | TABLET;ORAL | 019558-004 | Oct 25, 1988 | ⤷ Sign Up | ⤷ Sign Up |
| Merck | PRINIVIL | lisinopril | TABLET;ORAL | 019558-002 | Dec 29, 1987 | ⤷ Sign Up | ⤷ Sign Up |
| Merck | PRINIVIL | lisinopril | TABLET;ORAL | 019558-001 | Dec 29, 1987 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PRINIVIL
See the table below for patents covering PRINIVIL around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Romania | 80264 | ⤷ Sign Up | |
| Norway | 794010 | ⤷ Sign Up | |
| Bulgaria | 39467 | METHOD FOR PREPARING OF CARBOXYALKYL DIPEPTIDES | ⤷ Sign Up |
| Hungary | 182902 | PROCESS FOR PREPARING DIPEPTIDE DERIVATIVES WITH HYPOTENSIVE ACTIVITY | ⤷ Sign Up |
| Finland | 68405 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
